ONO 3307

Known as: ONO-3307 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1989-2017
012319892017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The protective effect of a new potent protease inhibitor, ONO 3307, in combination with a xanthine oxidase 1出 1bitor,allopurinol… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1993
1993
The effect of a novel synthetic trypsin inhibitor, 4-sulfamoylphenyl 4-guanidinobenzoate methanesulfonate (ONO-3307), on severe… (More)
Is this relevant?
1992
1992
To evaluate the effects of acute pancreatitis on the energy metabolism of the liver and on the fragility of hepatic cells and… (More)
Is this relevant?
1992
1992
The protective effect of a new potent protease inhibitor, ONO 3307, in combination with a xanthine oxidase inhibitor, allopurinol… (More)
Is this relevant?
1992
1992
To evaluate the effects of acute pancreatitis on hepatic function and hepatic cellular and subcellular organellar fragility, we… (More)
Is this relevant?
1990
1990
The effects of ONO-3307 (4-sulfamoylphenyl 4-guanidinobenzoate methanesulfonate), a new synthetic protease inhibitor, on… (More)
Is this relevant?
1989
1989
The effect of ONO-3307 (4-sulfamoyl phenyl-4-guanidinobenzoate methanesulfonate), a new protease inhibitor, was studied on… (More)
Is this relevant?